A detailed history of International Biotechnology Trust PLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 295,000 shares of AMLX stock, worth $1.46 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
295,000
Previous 25,000 1080.0%
Holding current value
$1.46 Million
Previous $539,000 902.04%
% of portfolio
1.83%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$18.08 - $23.45 $4.88 Million - $6.33 Million
270,000 Added 1080.0%
295,000 $5.4 Million
Q2 2023

Aug 08, 2023

BUY
$20.98 - $31.42 $524,500 - $785,500
25,000 New
25,000 $539,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.